Treatment Liquid contact surface, manually polished
Design Temperature -80 to 135°C (-112 to 275°F)
Design Pressure -1 to 10 bar(g) (-14.5 to 145 psi(g))
Note The assembled NovAseptic® Mixer may have
media for the enumeration of moulds and
yeasts in foods and beverages.
• Lab. Pract. 11: 109-112 (1962).
MOSSEL, D.A.A., KLEYNEN-SEMMELING, A.M.C., VINCENTIE,
H.M., BEERENS, H., and CATSARAS
sarcomeric and smooth) and nonmuscle (cytoplasmic)
myosins.1-3 The nonmuscle myosin II class contains
two isoforms: IIA and IIB, which exhibit 85% and 72%
amino acid identity in the motor domain and the rod
Kawamoto, S., and Adelstein, R. S., J. Cell Biol.,
112, 915-924 (1991).
5. Seri, M., et al., Nature Genet., 26, 103-105 (2000).
PHC 07/14-1
2014 Sigma-Aldrich Co. LLC. All rights reserved. SIGMA-ALDRICH
by Protein A chromatography.
Monoclonal Anti-Prion Protein recognizes amino acid
residues 109-112 of PrP from human, hamster and
feline by immunoblotting, ELISA, immunoprecipitation
and immunohistochemistry
Treatment Liquid contact surface, manually polished
Design Temperature -80 to 135°C (-112 to 275°F)
Design Pressure -1 to 10 bar(g) (-14.5 to 145 psi(g))
Note The assembled NovAseptic® Mixer may have
, and 25% glycerol.
Molecular mass: ∼60 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 82–112 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use
, and 25% glycerol.
Molecular mass: ∼60 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 82–112 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use
BAD on serine 112 and reverses BAD-induced cell
death. J. Biol. Chem., 278, 45358-45367 (2003).
PRECISIO is a registered trademark of Sigma-Aldrich
Co. LLC.
JB,BKR,MAM 10/14-1
2014 Sigma-Aldrich
., The PIM-2 kinase phosphorylates
BAD on serine 112 and reverses BAD-induced cell
death. J. Biol. Chem., 278, 45358-45367 (2003).
BKR,MAM 02/09-1
Sigma brand products are sold through Sigma-Aldrich
, and 25% glycerol.
Molecular mass: ∼60 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 82–112 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use
0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: ∼112 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 133–181 nmole/min/mg (see Figure 2)
Precautions and
multiple freeze/thaw cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 019K1614:
>95% (densitometry)
Figure 2.
Specific Activity of Lot Number 019K1614:
112 nmole/min/mg
Procedure
Preparation
Figure 1.
SDS-PAGE Gel of Lot Number SLBB4805V:
>95% (densitometry)
FGFR3
34
43
72
95
130
170
56
26
Figure 2.
Specific Activity of Lot Number SLBB4805V:
112 nmole/min/mg
0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: ∼112 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 133–181 nmole/min/mg (see Figure 2)
Precautions and
0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: ∼112 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 133–181 nmole/min/mg (see Figure 2)
Precautions and